Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers

NCT03512340 is registered in ClinicalTrials.gov with Surface Oncology as lead sponsor.

NCT NCT03512340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03512340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers
Lead sponsor
Surface Oncology
Phase
Phase 1
Overall status
Completed
Start date
March 13, 2018
Completion date
September 29, 2020
Enrollment
148 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid cancers, hematologic cancers